12th -
13th
March 2025
March 2025 | 
Sands Expo & Convention Centre, Singapore

Asia’s Leading ADC R&D & Manufacturing Conference – Uniting Leaders in the APAC Antibody- Drug Conjugates Market

12th -
13th
March 2025 | 
Sands Expo & Convention Centre, Singapore
📆 Add to Google Calendar
Attendees
0 +
Organizations
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

The Antibody Drug Conjugate (ADC) industry is poised for a transformative leap, with a surge of deals, innovations, and collaborations spotlighting Asia as the hub for next-generation ADC development. Asia is leading the way in advancing beyond traditional biosimilars, delving into novel payloads, conjugation technologies, and linkers. This heightened interest in ADCs is driven by the rising global incidence of cancer, which increases the demand for advanced therapeutic options. Breakthroughs in antibody technology are significantly boosting ADC efficacy and specificity, opening new possibilities for targeted treatments. This progress is bolstered by escalating investments and a growing number of FDA approvals, highlighting the field's potential and gaining regulatory confidence. 

Despite these exciting developments, the ADC sector faces critical challenges that demand innovative solutions and strategic planning. High development costs, intricate manufacturing processes, and potential toxicities are notable hurdles that require thoughtful strategies to overcome. 

ADC Asia Congress 2025 will provide a crucial platform that will bring together pioneers and key opinion leaders across mega-pharma and biotechnology focusing on Singapore, China, Japan, South Korea, Australia and the rest of Asia Pacific to discuss the latest technological innovations, clinical development, strategic collaborations, and common hurdles in the development of ADCs in the region. 

Event Highlights: 

  • Hear from 40+ leading industry experts and visionaries in the ADC field from Singapore, China, Japan, South Korea, and Australia on the latest advancements and future directions of Antibody Drug Conjugates.
  • Engage with 300+ attendees to explore forward-looking perspectives on ADC research and development and discover how strategic collaborations can drive innovation. 
  • Delve into Asia-Pacific-specific challenges and opportunities in ADC development. 
  • Discover real-world applications and success stories from top researchers and companies in the Asia-Pacific region. 
  • Explore breakthrough technologies and methodologies shaping the future of ADC development, including novel conjugation techniques and advanced drug delivery systems.
  • See the Poster Presentations to understand the latest R&D developments of ADC in Asia  

ADC 2025 is co-located with the 12th Annual Biologics Manufacturing Asia 2025, 9th Annual Biologistics World Asia 2025, 3rd Clinical Trial Festival Asia 2025, Biologics Digitilisation & A.I. World, and Asia-Pacific Bioprocessing Excellence Awards Gala Dinner 2025.

FEATURED CONTENT

BMA24_Yaron-Silberberg-Interview
Exclusive Interview Video: Yaron R. Silberberg, Chief Scientist & Head of Customer Solution Center, Ajinomoto CELLiST Korea
ADC25_Ebook2 Banner (Web) 2
How Are ADC Drug Partnerships Transforming China's Biopharma Industry?
ADC25_Ebook1 Banner (Web) 3
Are ADC Pipelines the Future of Biopharma? Exploring APAC's Breakthroughs & Advancements
Survey Results (Web Banner) (1)
Biologics Manufacturing Industry Survey Results
BMA24_Judy-Chou-Interview
Exclusive Interview Video: Judy Chou, President and Chief Executive Officer, AltruBio Inc., USA
BMA24_Zhang-Wei-Interview
BMA 2024: Exclusive Interview with Dr Zhang Wei is a Senior Scientist, A*STAR in Singapore
MicrosoftTeams-image (58)
Biomanufacturing Content Insights Bundle
MicrosoftTeams-image (57)
Interview with Zhang Wei
Ebook-website-cover-900-x-480
Unveiling the Top 10 Phase 3 Pipelines and Collaboration Opportunities
BMA24
Top 5 China Biomanufacturing Trends in 2024
BMA24_Biomanufacturing-Facility-APAC-1 (1)
Biomanufacturing Facilities in APAC
greater_china
APAC Biopharma Directory & Overview
BMA23-Ebook-cover-1500-x-1500-1-1024x1024
Singapore, The Next Asia Pacific BioMedical Hub
MicrosoftTeams-image-2022-08-05T090711.485
Explosion Of New Biologics Modalities
ADC Asia Congress 2025
.
.
.
.
.
.
.
.

THANK YOU TO OUR SUPPORTING PARTNERS









2025

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Heidi Wang

Heidi Wang, Ph.D.

CEO

OBI Pharma
Taiwan
Nitin Damle

Nitin Damle

Executive Vice President and Chief Innovation Officer

Sun Pharma Advanced Research Company Ltd.
India
Paul Moore

Paul Moore, Ph.D.

Chief Scientific Officer

Zymeworks
USA
Paul Song

Paul Song

Chief Scientific Officer

GeneQuantum Healthcare
China
Robert Chen

Robert (Rulei) Chen

Co-Founder & COO

Innolake Biopharm
China
Waranyoo Pholcharoen

Waranyoo Phoolcharoen

Chief Technical Officer and Co-Founder

Baiya Phytopharm
Indonesia
Xueming Qian

Xueming Qian

Founder, Chairman & CEO

Transcenta Holdings Ltd
China
Zou Bin

Zou Bin

CEO & Founder

Axcynsis Therapeutics
Singapore

DELEGATE REGISTRATION

Asia Biopharma (Biopharma in Asia, Academics)
Limited Super (By 13th September 2024)
SGD 1,495

Limited Special (By 15th November 2024)
SGD 1,695 

Early Bird (By 17th January 2025)
SGD 1,895

Standard Price
SGD 2,095
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
International Bio Pharma / Big Pharma
Limited Super (By 13th September 2024)
SGD 1,995

Limited Special (By 15th November 2024)
SGD 2,195 

Early Bird (By 17th January 2025)
SGD 2,395

Standard Price
SGD 2,595
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
Service / Solution Provider
Limited Super (By 13th September 2024)
SGD 4,295

Limited Special (By 15th November 2024)
SGD 4,495

Early Bird (By 17th January 2025)
SGD 4,695

Standard Price
SGD 4,895

Group Discount for Solution Providers & General Public: 
Buy 3 and get 10% off, Buy 5 get 15% off, Buy 6 and above, get 20% off

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

Asia Biopharma (Biopharma in Asia, Academics)
Limited Super (By 13th September 2024)
SGD 1,495

Limited Special (By 15th November 2024)
SGD 1,695 

Early Bird (By 17th January 2025)
SGD 1,895

Standard Price
SGD 2,095
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
International Bio Pharma / Big Pharma
Limited Super (By 13th September 2024)
SGD 1,995

Limited Special (By 15th November 2024)
SGD 2,195 

Early Bird (By 17th January 2025)
SGD 2,395

Standard Price
SGD 2,595
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
Service / Solution Provider
Limited Super (By 13th September 2024)
SGD 4,295

Limited Special (By 15th November 2024)
SGD 4,495

Early Bird (By 17th January 2025)
SGD 4,695

Standard Price
SGD 4,895

Group Discount for Solution Providers & General Public: 
Buy 3 and get 10% off, Buy 5 get 15% off, Buy 6 and above, get 20% off
Poster Presentation

ADC Congress Poster Presentation Guide (in conjuction with 12th Biologics Manufacturing Asia 2025)

Poster presentations are an excellent mechanism to facilitate the rapid communications of scientific ideas. In conjunction with the ADC Congress Asia 2025, the Poster Presentations seek to provide an ultimate platform for all emerging and established biopharmas, start-ups, academic & research institutions and solution providers to present in a less formal yet very interactive format with viewers to engage in discussion and 1-1 interactions. Featuring the latest research and solutions sharing, the ADC Congress Asia Poster Presentation 2025 offers potential for new collaboration opportunities & partnerships in the Life Sciences industry.

Showcase your groundbreaking achievements to more than 300+ attendees that will be present at the conference.

Download the Event Brochure Now!

FEATURED CONTENT

BMA24_Yaron-Silberberg-Interview
Exclusive Interview Video: Yaron R. Silberberg, Chief Scientist & Head of Customer Solution Center, Ajinomoto CELLiST Korea
ADC25_Ebook2 Banner (Web) 2
How Are ADC Drug Partnerships Transforming China's Biopharma Industry?
ADC25_Ebook1 Banner (Web) 3
Are ADC Pipelines the Future of Biopharma? Exploring APAC's Breakthroughs & Advancements
Survey Results (Web Banner) (1)
Biologics Manufacturing Industry Survey Results
BMA24_Judy-Chou-Interview
Exclusive Interview Video: Judy Chou, President and Chief Executive Officer, AltruBio Inc., USA
BMA24_Zhang-Wei-Interview
BMA 2024: Exclusive Interview with Dr Zhang Wei is a Senior Scientist, A*STAR in Singapore
MicrosoftTeams-image (58)
Biomanufacturing Content Insights Bundle
MicrosoftTeams-image (57)
Interview with Zhang Wei
Ebook-website-cover-900-x-480
Unveiling the Top 10 Phase 3 Pipelines and Collaboration Opportunities
BMA24
Top 5 China Biomanufacturing Trends in 2024
BMA24_Biomanufacturing-Facility-APAC-1 (1)
Biomanufacturing Facilities in APAC
greater_china
APAC Biopharma Directory & Overview
BMA23-Ebook-cover-1500-x-1500-1-1024x1024
Singapore, The Next Asia Pacific BioMedical Hub
MicrosoftTeams-image-2022-08-05T090711.485
Explosion Of New Biologics Modalities

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

Very eye-opening conference content delivered by distinguised  speakers across different companies and expertise.

Femdora Biosciences Sdn Bhd,  
 

Great meeting to meet supplier and learn new technology.

Novartis,  
 

The conference was well-organized, with a various speakers who were experts in their respective fields.

Takeda Manufacturing,  
 

Wide variety of topics covered, some interesting discussions ensued in panels and round tables. Also could connect with product developers/vendors and came to know about some new developments in biologics scientific space.

Hilleman Laboratories SG Ptd Ltd.,  
 

We were fortunate to participate in the conference, especially given Indonesia's current focus on developing its biopharmaceutical scheme. It was truly a remarkable experience witnessing the advancements in biologics and exploring new technologies driving progress in the industry. We eagerly anticipate joining future conferences with even more participants and exciting technological innovations

PT. Kalbio Global Medika,  
 

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

Apply For Speaking Opportunity

Featured Content Form